Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Beyond Weight Loss: Metabolic Improvements Participants also saw improvements in cardiometabolic health markers: Blood pressure: Systolic BP decreased by 7.4 mmHg Triglycerides: Fell by 30% HDL cholesterol: Increased by 8% (the "good" cholesterol) Liver fat: Reduced by 50% based on imaging studies HbA1c: Decreased by 0.4% even in participants without diabetes Visceral fat: Reduced by 42% (more than total weight loss percentage) Some of these improvements (particularly the visceral and liver fat reductions) are larger than the overall weight loss, which points to direct metabolic effects from the glucagon receptor activation
Obesity reviews, 17(10), 970-976
We advise scheduling an initial consultation with our Medical Director, Dr
The Canadian Perspective Canadian regulatory status for BPC-157 differs from some other jurisdictions
US$ 23.05
US$ 22.65
US$ 29.34
